BCL2L1 and ovarian carcinoma: Overexpression of Bcl-xL, a member of the BCL-2 protein family, has been observed in most recurrent chemo-resistant ovarian cancers, and inhibition of Bcl-xL in preclinical studies increased the chemo-sensitivity of OC cells [47].